InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the full record of transactions filed by Sheikh Michael, 董事长兼首席执行官. Director active across 1 company, notably Bioxytran, INC. Cumulatively, 7 disclosures have been logged. Activity tracked since 4 June 2021. The latest transaction was disclosed on 24 October 2024 (J). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 条申报中的 7 条
Michael K. Hargrave serves as Chief Executive Officer and Executive Vice President at BIOXYTRAN, INC. He leads the company with a strategic vision, focusing on growth and innovation. His role involves overseeing daily operations and formulating strategies to maximize shareholder value.